| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.55 | 0.0003 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |